San Francisco, CA – 25 May 2025
Key Highlights
> IPO Launch: Hinge Health targets $100 million raise through Nasdaq IPO under ticker HNGE.
>Strong Financials: Reported $17.1 million net income and 81% gross margin in 2024.
>AI-Powered Growth: Funds to scale personalized MSK care and expand into women’s health and global markets.
Financial Strength Backing Digital Health Expansion
Hinge Health enters the public markets with impressive financial momentum. In 2024, the company recorded a net profit of $17.1 million and maintained an 81% gross margin, reflecting its scalable and efficient care delivery model. With over 1,250 employer and health plan partners, Hinge Health serves millions of members across the U.S., helping them avoid surgeries and manage chronic pain through digital-first interventions.
Fueling Growth in AI-Driven MSK Innovation
The proceeds from the IPO are set to accelerate product development and expand the company’s footprint in adjacent care domains, including women’s pelvic health, post-operative recovery, and chronic pain management. Hinge Health’s evidence-based approach has demonstrated outcomes such as a 68% reduction in surgery risk and a 2.5x ROI for clients.
Combining Motion Sensors, Computer Vision, and Coaching
Hinge Health’s platform integrates real-time motion sensors, computer vision analysis, and behavioral health support, guided by AI to deliver personalized and accessible care at scale. The public offering will further enable investment in research, technology innovation, and international expansion.
About Hinge Health
Hinge Health is transforming MSK care with an AI-powered digital clinic designed to help people move beyond pain. By combining clinical care teams, wearable tech, and intelligent algorithms, the company delivers measurable health improvements and cost savings. Based in San Francisco, Hinge Health is trusted by hundreds of top employers and health plans.
More details: Hinge Health IPO Announcement
By
